(Q41605342)

5 October 2017

1 reference

title

Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies (English)

1 reference

5 October 2017

Spencer-Green G

1

1 reference

5 October 2017

Alter D

series ordinal

2

1 reference

5 October 2017

Welch HG

series ordinal

3

1 reference

5 October 2017

language of work or name

English

0 references

publication date

1 September 1997

1 reference

American Journal of Medicine

5 October 2017

1 reference

5 October 2017

103

1 reference

5 October 2017

3

1 reference

5 October 2017

242-248

1 reference

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

5 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

The 1982 revised criteria for the classification of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Autoantibody to centromere (kinetochore) in scleroderma sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Antinuclear antibody in systemic sclerosis (scleroderma).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Assessing quality of a diagnostic test evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Anti-Scl-70 antibodies detected by immunoblotting in progressive systemic sclerosis: specificity and clinical correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Antinuclear antibodies in patients with scleroderma (systemic sclerosis) and in their blood relatives and spouses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Frequency and clinical significance of anticentromere and anti Scl-70 antibodies in an English connective tissue disease population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Anticentromere antibodies (ACA): clinical distribution and disease specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Antinuclear antibodies in scleroderma, mixed connective tissue disease and "primary" Raynaud's phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Marker antibodies in scleroderma and polymyositis: clinical associations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

The CREST syndrome: a distinct serologic entity with anticentromere antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Cytogenetic survey in systemic sclerosis: correlation of aneuploidy with the presence of anticentromere antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Scl 70 antibody--a specific marker of systemic sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Autoantibody reactive with RNA polymerase III in systemic sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

The anticentromere antibody: disease specificity and clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjögren syndrome and scleroderma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Anticentromere antibody in localized scleroderma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Antibodies to centromere and centriole in scleroderma spectrum disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Antinuclear antibodies in the relatives of patients with systemic sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Anticentromere and anticentriole antibodies in the scleroderma spectrum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Antibodies to cellular antigens in Greek patients with autoimmune rheumatic diseases: anti-Ro(SSA) antibody a possible marker of penicillamine-D intolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Are ACA and Scl 70 antibodies mutually exclusive?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Racial differences in the frequencies of scleroderma-related autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

Eukaryotic expression of recombinant human centromere autoantigen and its use in a novel ELISA for diagnosis of CREST syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900023-5

10.1016/S0002-9343(97)00023-5

7 January 2021

Identifiers

DOI

1 reference

5 October 2017

1 reference